{
    "2019-04-19": [
        [
            {
                "time": "2019-04-19",
                "original_text": "【东吴医药】长春高新2019年一季报点评：生长激素快速放量叠加房地产板块结算，推动公司业绩增速高达74%",
                "features": {
                    "keywords": [
                        "长春高新",
                        "生长激素",
                        "快速放量",
                        "房地产板块",
                        "业绩增速"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "房地产"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-19",
                "original_text": "【华泰医药代雯团队】长春高新（000661.SZ）1Q19季报点评：生长激素领航，1Q19业绩再攀高峰",
                "features": {
                    "keywords": [
                        "长春高新",
                        "生长激素",
                        "业绩再攀高峰"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-19",
                "original_text": "东吴证券：长春高新买入评级",
                "features": {
                    "keywords": [
                        "长春高新",
                        "买入评级"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-04-19",
                "original_text": "『早安，新时代！』晨会早读2019/4/19:今日关注鱼跃医疗、长春高新、通威股份、金石资源、口子窖、金辰股份、思维列控",
                "features": {
                    "keywords": [
                        "长春高新",
                        "鱼跃医疗",
                        "通威股份",
                        "金石资源",
                        "口子窖",
                        "金辰股份",
                        "思维列控"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "新能源",
                        "资源",
                        "白酒",
                        "设备制造",
                        "轨道交通"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-04-19",
                "original_text": "【新时代医药 崔文亮团队】长春高新：一季报业绩超预期，生长激素龙头有望继续保持快速增长",
                "features": {
                    "keywords": [
                        "长春高新",
                        "一季报",
                        "业绩超预期",
                        "生长激素",
                        "龙头",
                        "快速增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-19",
                "original_text": "长春高新一季度净利3.65亿元 董事长马骥上年末持股3900股",
                "features": {
                    "keywords": [
                        "长春高新",
                        "一季度净利",
                        "3.65亿元",
                        "董事长马骥",
                        "持股3900股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-19",
                "original_text": "长春高新： 一季净利净赚3.65亿元 同比大增逾七成",
                "features": {
                    "keywords": [
                        "长春高新",
                        "一季净利",
                        "3.65亿元",
                        "同比大增",
                        "七成"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}